Communiqués SciBase Holding AB

Actions

Cours en clôture Nasdaq Stockholm 11/09/2026			Varia. 5j.	Varia. 1 janv.
16,75 ^SEK	-7,20 %		-6,94 %	-51,45 %

09/09	Calendrier du mercredi 9 septembre	FW
08/09	SciBase Holding AB reçoit une commande supplémentaire de Castle Biosciences Inc	CI

09/09	SciBase: Further progress with Castle Biosciences	AQ
08/09	SciBase receives additional order from Castle Biosciences, advancing the collaboration	AQ
03/09	SciBase: Fully guaranteed rights issue	AQ
03/09	SCIBASE RESOLVES ON A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 58 MILLION	AQ
20/08	SciBase (Q2 Review): Continued sales momentum, with capital raise on the horizon	AQ
19/08	SciBase (Q2 Initial take): Sales in line, but higher costs than expected	AQ
19/08	Interim report	AQ
28/07	SciBase announces changes in senior management	AQ
01/07	SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market	AQ
10/06	First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase	AQ
09/06	Study that highlights Nevisense potential for prediction of AD published in leading journal	AQ